Literature DB >> 35864433

Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM.

Brett W Sperry1, Timothy M Bateman2, Esma A Akin3, Paco E Bravo4, Wengen Chen5, Vasken Dilsizian5, Fabien Hyafil6, Yiu Ming Khor7, Robert J H Miller8, Riemer H J A Slart9,10, Piotr Slomka11, Hein Verberne12, Edward J Miller13, Chi Liu14.   

Abstract

This information statement from the Society of Nuclear Medicine and Molecular Imaging, American Society of Nuclear Cardiology, and European Association of Nuclear Medicine describes the performance, interpretation, and reporting of hot spot imaging in nuclear cardiology. The field of nuclear cardiology has historically focused on cold spot imaging for the interpretation of myocardial ischemia and infarction. Hot spot imaging has been an important part of nuclear medicine, particularly for oncology or infection indications, and the use of hot spot imaging in nuclear cardiology continues to expand. This document focuses on image acquisition and processing, methods of quantification, indications, protocols, and reporting of hot spot imaging. Indications discussed include myocardial viability, myocardial inflammation, device or valve infection, large vessel vasculitis, valve calcification and vulnerable plaques, and cardiac amyloidosis. This document contextualizes the foundations of image quantification and highlights reporting in each indication for the cardiac nuclear imager.
© 2022. American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  Basic science; diseases/processes; modalities

Year:  2022        PMID: 35864433     DOI: 10.1007/s12350-022-02985-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  138 in total

Review 1.  Recent Advances and Future Progress in PET Instrumentation.

Authors:  Piotr J Slomka; Tinsu Pan; Guido Germano
Journal:  Semin Nucl Med       Date:  2016-01       Impact factor: 4.446

2.  Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.

Authors:  Azadeh Ahmadian; Ashley Brogan; Jeffrey Berman; Aaron L Sverdlov; Gustavo Mercier; Michael Mazzini; Praveen Govender; Frederick L Ruberg; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2014-05-31       Impact factor: 5.952

3.  Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris.

Authors:  B L Zaret; H W Strauss; N D Martin; H P Wells; M D Flamm
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

4.  Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.

Authors:  Marc Hickeson; Mijin Yun; Alexander Matthies; Hongming Zhuang; Lars-Eric Adam; Lester Lacorte; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-02       Impact factor: 9.236

Review 5.  Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy.

Authors:  Paul E Kinahan; James W Fletcher
Journal:  Semin Ultrasound CT MR       Date:  2010-12       Impact factor: 1.875

6.  Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.

Authors:  K R Zasadny; R L Wahl
Journal:  Radiology       Date:  1993-12       Impact factor: 11.105

7.  Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors.

Authors:  Claude Nahmias; Lindi M Wahl
Journal:  J Nucl Med       Date:  2008-10-16       Impact factor: 10.057

8.  Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden.

Authors:  Jacek Kwiecinski; Sebastien Cadet; Marwa Daghem; Martin L Lassen; Damini Dey; Marc R Dweck; Daniel S Berman; David E Newby; Piotr J Slomka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-02       Impact factor: 9.236

9.  The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG.

Authors:  Jörg van den Hoff; Liane Oehme; Georg Schramm; Jens Maus; Alexandr Lougovski; Jan Petr; Bettina Beuthien-Baumann; Frank Hofheinz
Journal:  EJNMMI Res       Date:  2013-11-23       Impact factor: 3.138

10.  Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

Authors:  Sho Furuya; Osamu Manabe; Hiroshi Ohira; Kenji Hirata; Tadao Aikawa; Masanao Naya; Ichizo Tsujino; Kazuhiro Koyanagawa; Toshihisa Anzai; Noriko Oyama-Manabe; Tohru Shiga
Journal:  EJNMMI Res       Date:  2018-10-05       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.